Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.
about
Nutritional and Pharmacological Strategies to Regulate Microglial Polarization in Cognitive Aging and Alzheimer's Disease.Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's disease.Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.Cilostazol Suppresses Aβ-induced Neurotoxicity in SH-SY5Y Cells through Inhibition of Oxidative Stress and MAPK Signaling Pathway.
P2860
Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Cilostazol as an add-on therap ...... Taiwan: a case control study.
@ast
Cilostazol as an add-on therap ...... Taiwan: a case control study.
@en
type
label
Cilostazol as an add-on therap ...... Taiwan: a case control study.
@ast
Cilostazol as an add-on therap ...... Taiwan: a case control study.
@en
prefLabel
Cilostazol as an add-on therap ...... Taiwan: a case control study.
@ast
Cilostazol as an add-on therap ...... Taiwan: a case control study.
@en
P2093
P2860
P1433
P1476
Cilostazol as an add-on therap ...... Taiwan: a case control study.
@en
P2093
Chen-Yu Chien
Chun-Hung Chen
Shu-Yu Tai
Yuan-Han Yang
P2860
P2888
P356
10.1186/S12883-017-0800-Y
P577
2017-02-23T00:00:00Z
P6179
1083861524